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 What is angiosomal revascularisation?
 What literature is available to support decision making
when performing endovascular or open tibial artery
revascularisation?
 What arteries should actually be targeted during clinical
practice to get the best outcomes for the patient?Angiosome speciﬁc revascularisation, does the evidence support
it? The answer is actually yes and no, depending on the arteries
available and whether you accept the ﬁndings of the literature as it
stands. The evidence to support clinical decision making does exist,
but the highest quality papers are meta-analyses limited by the
fact that they can only include low quality cohort studies.1,2
Because of this, the strength of recommendations that can be
made is low, and the results are based on procedures involving
logical selection bias.
This educational review aims to discuss the main issues around
clinical decision making for angiosome directed revascularisation
via a clinical vignette, which would be seen commonly in clinical
practice (see Box. 1).
ANGIOSOMES
The angiosome concept was ﬁrst described in 1987, deﬁning an
angiosome as an area of tissue comprising skin, subcutaneous tis-
sue, fascia, muscle and bone supplied by a speciﬁc artery and
drained by a speciﬁc vein (Fig. 1).3 It was initially deﬁned by plastic
surgeons, so the anatomical assumptions were based on healthy
vessels, rather than those diseased enough to require intervention.4
In the most common angiosome model the foot consists of six
angiosomes: three arising from the posterior tibial artery, two from
the peroneal artery, and one from the anterior tibial artery (Fig. 1).
Patients with critical limb ischaemia who develop tissue loss in a
speciﬁc angiosome(s) and undergo tibial artery revascularisation
are considered to have a “direct reperfusion” when the artery of
interest supplies the area of tissue loss, and “indirect reperfusion”
when it does not. This is most commonly deﬁned in the literature
using the Taylor and Palmer model.4 As an example, the most
common form of direct reperfusion for tissue loss in the tips of the
toes would be via the anterior tibial artery, with indirect reper-
fusion via the peroneal artery.
Several other angiosome models have been suggested, and,
importantly, the changes in the foot vessels in peripheral vascular
disease, especially diabetes, may alter this strict angiosomal
perfusion pathway. This may confuse direct reperfusion between
the anterior and posterior tibial arteries, or lead to a theoretically
direct reperfusion (from the normal anatomical model described
by plastic surgeons), such as an anterior tibial angioplasty, not
actually reperfusing the area of interest because there are no distal
vessels supplying the tissue loss.5
CLINICAL SCENARIO
A 58 year old man presented with tissue loss to the tips of the ﬁrst
and second toes of the left foot (see Fig. 2 [patient consent pro-
vided]). He was a smoker, and was diagnosed diabetic when he
presented acutely 4 months earlier with severe foot sepsis of the
right foot and leg. When he presented, he was on aspirin 75 mg
but no lipid lowering therapy. Atorvastatin 40 mg was added on
presentation to hospital. Despite treatment the right leg was
amputated owing to a combination of non-reconstructable disease
and extensive tissue loss. The left foot was asymptomatic at that1078-5884/ 2018 European Society for Vascular Surgery. Published by
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attend these appointments until he was forced to by the artiﬁcial
limb centre because of new tissue loss in his left foot. At that point
he had palpable femoral and popliteal pulses, with incompressible
calf vessels, a toe brachial index (TBI) of 0.3, and an absolute toe
pressure of 38 mmHg. Sensation was lost below the level of the
ankle.
Computed tomography angiography (CTA) showed essentially
normal arteries to the knee with severe tibial disease and no
obvious target artery in the foot. After multidisciplinary team
discussion he underwent tibial angioplasty. A 4 Fr sheath was
inserted into the common femoral artery under ultrasound guid-
ance. Digital subtraction angiography from this showed good ﬂow
to the trifurcation with three vessel tibial disease. The anterior
tibial artery appeared to be occluded near its origin, as was the
posterior tibial. The peroneal artery was stenosed at origin but
appeared the best vessel. Because both CTA and digital subtraction
angiography from a common femoral sheath can miss target ves-
sels in the foot, selective angiography through a 4 Fr catheter was
performed from the popliteal trifurcation (see Fig. 3). Delayed
phase imaging showed that the anterior tibial artery was patent to
the mid-calf but occluded distally with reconstitution of the dor-
salis pedis in the foot. The plantar arch was heavily diseased and
probably occluded.
The operator chose to try and reconstitute the anterior tibial
artery as this would provide direct reperfusion of the angiosome
affected. Re-entry at the dorsalis pedis failed (Fig. 4). The peroneal
artery was therefore treated successfully (Fig. 5).
The post-procedural TBI was 0.45, with an absolute pressure of
63 mmHg. The increase in perfusion pressure was sustained and
medical therapy optimised. He was treated in a total contact cast.Figure 1. The most common angiosome model of the leg and foot.
Reproduced from Iida et al.3
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Figure 2. Pattern of tissue loss.
2 EdutorialThe wounds would not fully heal after several months, despite a
sustained increase in TBI. He continued to miss outpatient ap-
pointments and ultimately re-presented with severe infected tis-
sue loss requiring major amputation.
In this case, direct reperfusion of the toes via the dorsalis pedis
angiosome was attempted but failed; therefore, indirect reperfu-
sion was achieved via the peroneal artery. Are the clinical results
what we would expect based on the literature?
THE EVIDENCE FOR ANGIOSOME SPECIFIC
REVASCULARISATION
As already mentioned, the literature is very low quality. In terms of
comparing direct and indirect revascularisation outcomes, meta-
analysis offers the best way to summarise ﬁndings.1,6 There are
no randomised trials, and the cohort studies available for meta-
analysis have a median Newcastle Ottawa Score (a marker of
study quality scored from 0 to 9) of 5, so are of moderate quality.
GRADE analysis (which gives the strength of recommendation for
an individual outcome from meta-analysis) is low or very low for allFigure 3. Selective digital subtraction angiography from the popliteal artery,
left leg. (A) Antero-posterior view below the knee. (B) Lateral view of the
foot. (A) Inﬂow shows a moderate popliteal stenosis. (A) The anterior tibial
has a stenosis at origin with mid-vessel occlusion (B) and some reconsti-
tution of the dorsalis pedis in the foot. (A) Peroneal origin stenosis with
moderate multilevel disease; (B) the peroneal artery is then the best vessel
at the ankle but with minimal collateralisation into the foot. (A) Severe
posterior tibial artery disease from origin; (B) it occludes above the ankle
with no foot arch reconstitution.
Figure 4. Failed re-entry into the dorsalis pedis.
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the results discussed.6
With this in mind, for both endovascular and open surgery, direct
angiosomal reperfusion is superior to indirect reperfusion for
wound healing (odds ratio [OR] 0.51, 95% conﬁdence interval [CI]
0.39e0.68; p < .001) and limb salvage (OR 0.37, 95% CI 0.24e0.58;
p < .001) (see Table 1). Although the effect size is marginally
stronger for open surgery, the difference between direct and indi-
rect revascularisation is more pronounced for endovascular inter-
vention. All case series inherently contain selection bias, and the
majority of the endovascular selection bias (direct fails so indirect
becomes the default) is highlighted by the clinical case presented.
Endovascular clinical context
The clinical scenario presented is an example of indirect peroneal
angiosomal reperfusion of the toes.The patient had a poor outcome
in terms of wound healing, then eventually lost his leg, despite a
presumably patent angioplasty site based on sustained improve-
ments in pressure readings. This ﬁts with the ﬁndings in the litera-
ture, but, more importantly, highlights the essential problemwith its
selection bias; this man could only have an indirect reperfusion
because there were no target arteries in the foot. His outcome was
therefore always likely to be worse than a patient with a patent foot
vessel, who usually has a direct angioplasty or bypass option. If the
dorsalis pedis had been very good in this man repeat angioplasty
could have been tried, possibly via a retrograde dorsalis pedisscularisation: Does the Evidence Support It?, European Journal of Vascular
Figure 5. Post-angioplasty angiography. The popliteal and peroneal have been successfully treated by plain balloon angioplasty. (A) The peroneal is now ﬁlling
preferentially. (B) The distal peroneal also ﬁlls preferentially. (C) The short remaining dorsalis pedis does still ﬁll as it did pre-procedure on late angiography,
but the foot arch still appears absent.
Angiosome Speciﬁc Revascularisation 3puncture, or he could have been offered open bypass (or entry into
the BASIL 2 randomised trial).7 The presence of a useable dorsalis
pedis would have moved him from the indirect to direct group and
he may have fared better, all because of the good runoff vessel
rather than an active choice between direct or indirect reperfusion.
When tibial angioplasty was ﬁrst performed there was a trend
towards preserving the best tibial vessel and treating the easy or
“safe” vessel (usually the peroneal) leaving the best vessel for
bypass if the angioplasty failed. This approach is doomed to failure,
and such selection bias may contribute to the results in Table 1,
because indirect reperfusion leads to worse outcomes. This is
where a balanced decision making process between endovascular
and open surgery is so important, because while tibial angioplasty
is suitable for the majority of these patients, a strict endovascular
ﬁrst policy may lead to worse outcomes in patients needing open
surgery after attempted endovascular intervention.7
Combined revascularisation
Another concept for tibial revascularisation is combined revascu-
larisation, i.e., performing direct and indirect revascularisation at
the same time. There is little evidence in this area: two case series
and a small randomised trial.5,8,9 The results from both endovas-
cular series are the same, so the results presented here are from
the authors own unit.5
Essentially, if one can open more than one tibial vessel during
tibial angioplasty, the results for amputation free survival areTable 1. Summary of meta-analysis ﬁndings for direct versus indirect angiosom
No. of studies
(total limbs)
Direct (n) Indirect (n) HG I2
Wound healing
All studies 18 (2,998) 1,557 1,441 56
Endovascular 11 (2,174) 1,147 1,027 61
Open bypass 8 (865) 482 383 48
Limb salvage
All studies 20 (3,144) 1,613 1,531 73
Endovascular 12 (2,243) 1,158 1,085 81
Open bypass 8 (866) 482 384 33
Mortality
All studies 9 (1,213) 641 572 56
Endovascular 3 (303) 151 152 0
Open bypass 3 (237) 138 99 0
Note. Modiﬁed from Dilaver et al.6 HG ¼ heterogeneity; OR ¼ odds r
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the results from combined angioplasty were no better than direct,
but were signiﬁcantly better than indirect after adjusting for
confounders. The numbers are low in this series (250 total, only 22
in the combined revascularisation group) and there is inherent
selection bias for the same reasons as the clinical case presented;
if the patient has the potential to open more than one tibial vessel
it is likely that they have better runoff. Nevertheless, it represents
the only confounder adjusted series on combined endovascular
reperfusion in the literature.
A randomised trial comparing endovascular treatment of one
tibial vessel with more than one tibial vessel has been published
recently.8 The set up was subtly different from that comparing
combined with direct or indirect because the angiosome was not
considered, just the technical ability to open multiple vessels. The
foot arch had to be patent for inclusion. However, the results are
likely to be biased because there were signiﬁcantly more direct
reperfusions in the group of patients having multiple vessels
treated (75% vs. 40%; p ¼ .004). There appeared to be no differ-
ence when pure angiosomal revascularisation was examined, but
the numbers in the trial were too small to adjust accurately for
major confounders like this. We can therefore choose whichever
story ﬁts our own conﬁrmation bias to explain the results, if we
accept that they are accurate. Either direct reperfusion (here more
than one tibial vessel) was better than indirect (single vessel), or
supply more oxygenated blood to the ischaemic area by opening
multiple tibial vessels and get a better result (more on that in theal revascularisation.
(%) HG p OR (95% CI) Overall effect z p
.002 0.51 (0.39e0.68) 4.57 <.001
.004 0.48 (0.34e0.67) 4.30 <.001
.06 0.64 (0.39e1.07) 1.71 .09
<.001 0.37 (0.24e0.58) 4.36 <.001
<.001 0.36 (0.20e0.66) 3.30 .001
.17 0.56 (0.33e0.94) 2.18 .03
.02 0.73 (0.45e1.18) 1.29 .2
.54 1.16 (0.69e1.96) 0.57 .57
.61 0.35 (0.16e0.78) 2.59 .01
atio; CI ¼ conﬁdence interval.
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Figure 6. KaplaneMeier graph comparing amputation free survival in pa-
tients undergoing combined approach angioplasty vs. the indirect and
direct approaches. Adjusted hazard ratio (AHR) 0.492 (p ¼ .082) for com-
bined vs. direct, AHR 0.426 (p¼ .037 for combined vs. indirect. Reproduced
from Ambler et al.5
Box 2 Take home messages
 An angiosome is an area of tissue comprising skin,
subcutaneous tissue, fascia, muscle, and bone supplied by
a speciﬁc artery and drained by a speciﬁc vein. It was
deﬁned in healthy people.
 The angiosome literature for peripheral vascular
intervention is low quality and clearly contains bias.
 The “classic” angiosome model may not apply to patients
with peripheral vascular disease, especially diabetics.
 Reperfusion via the artery leading directly to the area of
tissue ischaemia is more important than sticking to the
“classic” angiosome model.
 If feasible, opening multiple arteries endovascularly may be
useful provided at least one supplies the ischaemic area
directly.
 The angiosome model appears less relevant in open surgery
than endovascular intervention.
4 Edutorial‘Breakdown of the classic angiosome model’ section). The afore-
mentioned case series suggest that combined reperfusion (direct
and indirect) was no better than direct alone, but the reported
results of the trial did not examine this speciﬁcally.
Open surgery clinical context
Open surgical bypass is worth considering separately because the
outcomes are slightly different to the endovascular group. The
signiﬁcance between direct and indirect reperfusion is lost for
wound healing, and diminished for limb salvage and mortality
when comparing direct and indirect revascularisation (Table 1).
Again, in the cohort literature there is selection bias because
the majority of (now historical) studies with large patient numbers
included in meta-analysis offered a bypass ﬁrst approach for
excellent runoff and the presence of a vein for conduit.1,6 In open
surgery the old adage of “restoring in line ﬂow” to the area has
always been followed because it seems to be common sense. And
common sense prevails here because a direct open operation is
superior to an indirect; however, how many surgeons would
bypass to a peroneal artery if a posterior or anterior tibial with
ﬂow into the foot were available for tissue loss in the foot? Se-
lection bias will again be rife.
Accurately comparing open and endovascular intervention for
angiosome speciﬁc outcomes is impossible from the literature.
However, the comparative results of open and endovascular tibial
revascularisation have been contentious enough for the BASIL 2
randomised trial of the endovascular ﬁrst versus open ﬁrst
approach to tibial intervention to exist and to currently be
recruiting.10
Breakdown of the classic angiosome model and other
concepts
Looking back at the clinical case above and at Fig. 3(B), the angiosome
model is not neatly applicable to this man’s foot. Even if “direct”
reperfusion via the anterior tibial artery was possible, he had no
named vessels in his foot supplying the toes, so revascularisation
would not be truly direct.This happens commonly in diabetes but it is
unclear how important it is when comparing direct and indirect
outcomes.
The ‘functional angiosome’ is the body’s response to adapt to
ischaemia and has mainly been deﬁned through animal studies.11Please cite this article in press as: Stimpson AL, et al., Angiosome Speciﬁc Reva
and Endovascular Surgery (2018), https://doi.org/10.1016/j.ejvs.2018.07.027This is when natural interconnections, or choke vessels, between
major, named arteries (usually in the foot) dilate in response to
ischaemia. While there is no standardised deﬁnition, a collateral is
the end result of permanent dilation of a choke vessel in response
to ischaemia.
This is where imaging studies help clinical decision making. In a
recent series of 120 peroneal bypasses, the patency of the foot
arch was more important for a good outcome than looking at the
“classic” angiosome location of the wound.12 So we are back to
inline ﬂow, even if it’s not “direct” in the traditional sense; if the
peroneal collateralises into the foot arch as a functional angio-
some, to the extent that a distal bypass will run, the patient will do
well. However this is not the whole picture because even in an-
gioplasty, which may be successful with no foot arch, direct
reperfusion is superior to indirect in diabetic patients with almost
no foot vessels remaining.13
Perfusion studies tend to show global increases in foot perfusion
after tibial reperfusion, whether direct or indirect, with no speciﬁc
differences in diabetic patients.14,15 These studies also tend to show
a non-angiosomal pattern of ischaemia and reperfusion in critical
ischaemia, although they are small series which did not examine this
speciﬁcally. This implies that it might be most important to supply a
greater volume of oxygenated blood to the foot by whatever means,
and that because a direct reperfusion is more likely to involve a
patient with a patent foot vessel or arch, they fare better after
intervention. This also leads to the theory that patients undergoing
indirect open bypass may do better than the same patient under-
going indirect endovascular intervention, because the bypass pro-
vides a greater volume of blood. There are counter arguments to
this: tibial angioplasty only needs to work long enough to heal the
wound and can be repeated; the leg is less likely to be lost if a tibial
angioplasty occludes than if a bypass occludes, and so on, but all of
the arguments for and against are essentially cognitive bias because
they are based on inconclusive data.
Summary
So does the evidence support angiosome speciﬁc revascularisa-
tion? Yes, in the limited way that it is able to, as it supports the
commonsense notion of restoring in line ﬂow to the area of
ischaemia for the best outcomes. No, in that if you stick rigidly to
the old Taylor and Palmer model you will get caught out because
what is actually called an angiosome in disease states is debatable.
Perfusion studies show that maximising perfusion is key, and this
might be via an indirect peroneal reperfusion if this collateralises
signiﬁcantly into the foot arch. Indirect reperfusion without a goodscularisation: Does the Evidence Support It?, European Journal of Vascular
Angiosome Speciﬁc Revascularisation 5vessel leading to the ischaemic area may be technically successful
as in the case scenario, but will lead to worse outcomes because it
is a great example of selection bias in clinical practice and for this
reason it is a useful prognostic indicator. Further randomised trials
in this area would add little and are potentially harmful, because
although the existing literature is biased it can still guide us to the
right strategy: target the best vessels with runoff leading to the
ischaemic tissue (see Box. 2).
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